David D Brand Selected Research

HLA-DR1 Antigen (HLA DR1 Antigen)

1/2014	Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.
5/2012	Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
7/2010	An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David D Brand Research Topics

Disease

29	Arthritis (Polyarthritis) 01/2022 - 01/2002
14	Experimental Arthritis 12/2021 - 01/2002
10	Inflammation (Inflammations) 12/2021 - 03/2002
9	Rheumatoid Arthritis 12/2021 - 03/2002
6	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 08/2003
2	Osteoarthritis 10/2016 - 03/2002
2	Fibrosis (Cirrhosis) 05/2016 - 08/2010
2	Hypertension (High Blood Pressure) 05/2016 - 01/2016
2	Bronchiolitis Obliterans Syndrome 08/2010 - 03/2007
2	Bronchiolitis 12/2009 - 11/2007
2	Hypersensitivity (Allergy) 12/2009 - 03/2007
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Periodontal Diseases (Periodontal Disease) 10/2016
1	Proteinuria 05/2016
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2016
1	Abdominal Aortic Aneurysm 01/2016
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 11/2012
1	Atherosclerosis 11/2012
1	Lung Injury 08/2010
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2010
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 03/2010
1	Vasculitis (Vasculitides) 12/2009
1	Reperfusion Injury 02/2008
1	Hyperplasia 03/2007

Drug/Important Bio-Agent (IBA)

16	Collagen Type II (Type II Collagen)IBA 12/2021 - 01/2002
9	CytokinesIBA 12/2021 - 01/2002
9	Peptides (Polypeptides)IBA 12/2016 - 08/2004
6	CollagenIBA 10/2016 - 03/2004
5	EpitopesIBA 01/2022 - 03/2002
5	EnzymesIBA 01/2018 - 03/2002
5	AntigensIBA 01/2014 - 01/2004
5	Collagen Type V (Type V Collagen)IBA 11/2012 - 03/2007
4	AntibodiesIBA 12/2021 - 03/2009
4	Matrix Metalloproteinases (MMPs)IBA 10/2016 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 12/2014 - 01/2004
3	Freund's AdjuvantIBA 12/2021 - 01/2007
3	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 01/2014 - 07/2010
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	hydroxide ionIBA 12/2021 - 01/2021
2	20-hydroxyvitamin D3IBA 12/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2019 - 10/2017
2	Interleukin-4 (Interleukin 4)IBA 12/2016 - 09/2011
2	ImmunosorbentsIBA 10/2016 - 01/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2016 - 01/2016
2	Angiotensin IIIBA 05/2016 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 08/2010 - 12/2009
2	AutoantigensIBA 07/2010 - 03/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009 - 02/2008
2	tetracycline CMT-3IBA 02/2008 - 03/2007
1	Vitamin D FDA LinkGeneric 12/2021
1	Calcitriol (Calcijex)FDA LinkGeneric 12/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 01/2019
1	protein kinase DIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Prostaglandins EIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	EicosanoidsIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 12/2016
1	LigandsIBA 12/2016
1	Syk KinaseIBA 12/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2016
1	Anti-Citrullinated Protein AntibodiesIBA 10/2016
1	SodiumIBA 05/2016
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2016
1	Testosterone (Sustanon)FDA Link 05/2016
1	Type 1 Angiotensin ReceptorIBA 05/2016
1	AngiotensinogenIBA 05/2016
1	HLA-DR Antigens (HLA-DR)IBA 01/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	AngiotensinsIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2014
1	NucleosidesIBA 10/2011
1	Fc Receptors (Fc Receptor)IBA 09/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 08/2010
1	Interleukin-6 (Interleukin 6)IBA 08/2010
1	Caspase 1 (ICE Protease)IBA 04/2010
1	InflammasomesIBA 04/2010
1	Protein Kinases (Protein Kinase)IBA 03/2010
1	Interferon-gamma (Interferon, gamma)IBA 12/2009
1	InterleukinsIBA 12/2009
1	Indicators and Reagents (Reagents)IBA 03/2009
1	Matrix Metalloproteinase InhibitorsIBA 02/2008
1	Metalloproteases (Metalloproteinases)IBA 02/2008
1	Tissue Inhibitor of Metalloproteinase-2IBA 03/2007
1	Tissue Inhibitor of Metalloproteinase-1IBA 03/2007
1	EmulsionsIBA 01/2007
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2006
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2004
1	Cyanogen BromideIBA 11/2004
1	Immunoglobulins (Immunoglobulin)IBA 11/2004

Therapy/Procedure

3	Therapeutics 12/2021 - 01/2010
2	Lung Transplantation 08/2010 - 02/2008
1	Castration 05/2016
1	Intravenous Injections 08/2010
1	Transplantation 02/2008